| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 9 |
| GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: Q4Q2G2
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 139 | 141 | PF00675 | 0.614 |
| CLV_PCSK_KEX2_1 | 139 | 141 | PF00082 | 0.672 |
| CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.375 |
| CLV_PCSK_PC1ET2_1 | 139 | 141 | PF00082 | 0.565 |
| CLV_PCSK_PC1ET2_1 | 39 | 41 | PF00082 | 0.376 |
| CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.574 |
| DOC_MAPK_gen_1 | 9 | 17 | PF00069 | 0.564 |
| DOC_PP1_RVXF_1 | 124 | 130 | PF00149 | 0.422 |
| DOC_PP1_RVXF_1 | 180 | 187 | PF00149 | 0.477 |
| DOC_USP7_UBL2_3 | 139 | 143 | PF12436 | 0.312 |
| LIG_14-3-3_CanoR_1 | 11 | 16 | PF00244 | 0.522 |
| LIG_14-3-3_CterR_2 | 194 | 197 | PF00244 | 0.458 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.541 |
| LIG_FHA_1 | 12 | 18 | PF00498 | 0.532 |
| LIG_LIR_Gen_1 | 168 | 177 | PF02991 | 0.428 |
| LIG_LIR_Gen_1 | 2 | 12 | PF02991 | 0.527 |
| LIG_LIR_Nem_3 | 130 | 134 | PF02991 | 0.454 |
| LIG_LIR_Nem_3 | 2 | 8 | PF02991 | 0.596 |
| LIG_LIR_Nem_3 | 35 | 41 | PF02991 | 0.603 |
| LIG_LYPXL_S_1 | 68 | 72 | PF13949 | 0.408 |
| LIG_LYPXL_yS_3 | 100 | 103 | PF13949 | 0.377 |
| LIG_LYPXL_yS_3 | 69 | 72 | PF13949 | 0.321 |
| LIG_SH2_CRK | 5 | 9 | PF00017 | 0.539 |
| LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.382 |
| LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.376 |
| LIG_SH3_3 | 31 | 37 | PF00018 | 0.557 |
| LIG_SUMO_SIM_par_1 | 13 | 18 | PF11976 | 0.559 |
| LIG_TYR_ITIM | 67 | 72 | PF00017 | 0.384 |
| LIG_UBA3_1 | 159 | 164 | PF00899 | 0.505 |
| LIG_WRC_WIRS_1 | 20 | 25 | PF05994 | 0.593 |
| MOD_CK1_1 | 32 | 38 | PF00069 | 0.453 |
| MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.684 |
| MOD_GlcNHglycan | 167 | 170 | PF01048 | 0.501 |
| MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.414 |
| MOD_N-GLC_1 | 118 | 123 | PF02516 | 0.560 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.422 |
| MOD_NEK2_1 | 10 | 15 | PF00069 | 0.377 |
| MOD_NEK2_1 | 29 | 34 | PF00069 | 0.378 |
| MOD_PIKK_1 | 118 | 124 | PF00454 | 0.532 |
| MOD_PKA_2 | 10 | 16 | PF00069 | 0.386 |
| MOD_Plk_1 | 118 | 124 | PF00069 | 0.653 |
| MOD_Plk_1 | 152 | 158 | PF00069 | 0.466 |
| MOD_Plk_4 | 51 | 57 | PF00069 | 0.364 |
| MOD_SUMO_for_1 | 162 | 165 | PF00179 | 0.516 |
| MOD_SUMO_for_1 | 45 | 48 | PF00179 | 0.469 |
| TRG_DiLeu_BaEn_1 | 180 | 185 | PF01217 | 0.567 |
| TRG_DiLeu_BaLyEn_6 | 62 | 67 | PF01217 | 0.347 |
| TRG_ENDOCYTIC_2 | 100 | 103 | PF00928 | 0.452 |
| TRG_ENDOCYTIC_2 | 170 | 173 | PF00928 | 0.574 |
| TRG_ENDOCYTIC_2 | 5 | 8 | PF00928 | 0.510 |
| TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.387 |
| TRG_ER_diArg_1 | 186 | 189 | PF00400 | 0.648 |
| TRG_ER_diArg_1 | 88 | 91 | PF00400 | 0.447 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P6S8 | Leptomonas seymouri | 61% | 100% |
| A0A0S4KIP5 | Bodo saltans | 37% | 99% |
| A0A1X0PAY8 | Trypanosomatidae | 46% | 100% |
| A0A3S7X8G4 | Leishmania donovani | 96% | 100% |
| A4HBA1 | Leishmania braziliensis | 85% | 100% |
| A4IAE9 | Leishmania infantum | 96% | 100% |
| C9ZLU5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
| E9B5H3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |